High salt intake: A cause of blood pressure-independent left ventricular hypertrophy?

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2426-2429

  Burnier, Michel ^a,b   Phan, Olivier ^a   Wang, Qing ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Blood pressure; Cardiac hypertrophy; Potassium; Sodium

Indexed keywords

ALCOHOL; ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; MINERALOCORTICOID; POTASSIUM; RENIN; SODIUM;

AGE; ALCOHOL CONSUMPTION; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; FOOD COMPOSITION; GENDER; GENETIC POLYMORPHISM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEREDITY; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; HYPOKALEMIA; ISCHEMIC HEART DISEASE; KIDNEY HYPERTROPHY; METABOLIC ALKALOSIS; NONHUMAN; NOTE; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; STROKE; SUDDEN DEATH;

ANIMALS; BLOOD PRESSURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MICE; ORGAN SIZE; SODIUM CHLORIDE; SODIUM, DIETARY;

EID: 34548395518     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm321     Document Type: Note

References (20)

1. Levy D, Garrison RJ, Savage DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl J Med 1990; 322: 1561-1566
2. Verdecchia P, Schillaci G, Borgioni C et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54
3. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110
4. Dahlof B, Devereux RB, Kjeldsen SE et al. and the LIFE (Losartan Intervention for Endpoint Reduction) Study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002; 359: 995-1003
5. Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536
6. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension 2000; 35: 985-991
7. Holtwick R, van Eickels M, Skryabin BV et al. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 2003; 111: 1399-1407
8. Dvorak P, Kramer HJ, Backer A et al. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats. Kidney Blood Press Res 2004; 27: 248-258
9. Gupta S, Young D, Sen S. Inhibition of NF-kB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005; 289: H20-H29
10. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-956
11. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 1994; 89: 1041-1050
12. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium on large artery structure and function in hypertension. Cardiovasc Res 2000; 46: 269-276
13. Morgan T, Brunner H, Aubert J et al. Cardiac hypertrophy depends upon sleep blood pressure: A study in rats. J Hypertens 2000; 18: 445-451
14. Yuan B, Leenen F. Dietary sodium intake and left ventricular hypertrophy in nomotensive rats. Am J Physiol, 1991; 261: H1397-H1401
15. Wang Q, Hummler E, Nussberger J et al. Blood pressure, cardiac and renal responses to salt and DOCA in mice: Role of renin genes. J Am Soc Nephrol 2002; 13: 1509-1516
16. Wang Q, Burnier M. Sodium modulates the mineralocorticoid-induced cardiac and renal hypertrophy independently of blood pressure in one-renin gene mice. J Hypertension 2004; 22 [Suppl. 1]: S10 (abstract)
17. Wang Q, Clement S, Gabbiani G et al. Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodelling and fibrosis under normal salt diet. Am J Physiol 2004; 286: F1178-F1184
18. Wang Q, Domenighetti A, Pedrazzini T, Burnier M. Potassium supplementation reduces cardiac and renal hypertrophy independent of blood pressure in DOCA/salt mice. Hypertension 2005; 46: 547-554
19. Evans SJ, Levi AJ, Jones JV. Low magnesium enhances the proarrhythmic effect of low potassium in the hypertrophied rat heart but not in the normal rat heart. J Hypertens 1996; 14: 635-44
20. Wang Q, Burnier M. What is the normal blood pressure in one-renin gene deoxycorticosterone - acetate/salt mice with cardiac hypertrophy? J Hypertens 2007, in press (abstract)